PaulAndrewReyfmanMD
Pulmonology • Chicago, ILAsthma & COPD, Critical Care Medicine, Interstitial Lung Diseases
Physician
Dr. Reyfman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Galter Pavilion, 675 N St Clair St Ste 18-250
Chicago, IL 60611Phone+1 312-695-1800
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2017
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2011 - 2014
Columbia University Vagelos College of Physicians and SurgeonsClass of 2011
Certifications & Licensure
NY State Medical License 2012 - Present
IL State Medical License 2014 - 2023
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 1 citationsEfficacy and safety of gefapixant in women with chronic cough and cough-induced stress urinary incontinence: a phase 3b, randomised, multicentre, double-blind, placebo...Surinder S Birring, Linda Cardozo, Roger Dmochowski, Peter Dicpinigaitis, Amna Afzal
The Lancet. Respiratory Medicine. 2024-11-01 - 41 citationsMitochondrial integrated stress response controls lung epithelial cell fate.SeungHye Han, Minho Lee, Youngjin Shin, Regina Giovanni, Ram P Chakrabarty
Nature. 2023-08-01 - 15 citationsThe Efficacy and Safety of Gefapixant in a Phase 3b Trial of Patients with Recent-Onset Chronic Cough.Lorcan McGarvey, Mandel Sher, Yury Grigorievich Shvarts, Susan Lu, Wen-Chi Wu
Lung. 2023-04-01
Press Mentions
Northwestern Doctor Awarded ATS Foundation/Boehringer Ingelheim Fellowship for IPF ResearchApril 15th, 2019
ATS Foundation/Boehringer Ingelheim Pharmaceuticals Inc. Research Fellowship in Idiopathic Pulmonary FibrosisApril 8th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
